ANEB
NASDAQ · Pharmaceuticals
Anebulo Pharmaceuticals Inc
$1.03
+0.01 (+0.98%)
Open$1.05
Previous Close$1.02
Day High$1.05
Day Low$1.01
52W High$3.42
52W Low$0.30
Volume—
Avg Volume30.9K
Market Cap42.82M
P/E Ratio—
EPS$-0.19
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+4,753.4% upside
Current
$1.03
$1.03
Target
$49.99
$49.99
$34.23
$49.99 avg
$60.95
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.41M | 5.09M | 4.82M |
| Net Income | 1.02M | 757.9K | 675.0K |
| Profit Margin | 18.8% | 14.9% | 14.0% |
| EBITDA | 1.84M | 1.51M | 1.49M |
| Free Cash Flow | 747.3K | 835.9K | 744.4K |
| Rev Growth | +9.4% | +17.9% | +10.5% |
| Debt/Equity | 0.83 | 0.81 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |